Short answer: To start a longevity clinic online, build a program that begins with labs and a licensed provider evaluation, then offers only treatments a provider decides are appropriate, such as hormone therapy, NAD+ or peptides through legitimate prescription pathways, with wearables for ongoing data. Compliance is the foundation: compounded drugs are not FDA-approved, and claims about aging or disease need real substantiation.
Longevity is one of the most talked-about categories in digital health, and many founders want to start a longevity clinic because patients are asking for a more proactive, data-driven relationship with their health. The opportunity is real. So is the scrutiny. Longevity sits where hormones, peptides, compounded medications and bold marketing meet, which is exactly where FDA and the FTC pay attention.
This guide covers how to design a longevity telehealth business the right way: program structure, each clinical building block, the compliance rules that matter most, the patient experience and the launch steps.
What is an online longevity clinic?
An online longevity clinic is a digital clinic focused on proactive health: understanding a patient’s current health markers, reviewing them with a licensed provider and building an individualized plan that may include lifestyle guidance, monitoring and, where a provider decides it is appropriate, prescription treatment. Everything runs online: branded intake, lab ordering, provider review, e-prescribing, pharmacy fulfillment, messaging and follow-up.
What separates a credible longevity brand from a supplement shop with a doctor attached is structure. Labs come first. A licensed provider evaluates every patient. Treatments come only through legitimate prescription pathways. Marketing describes the program honestly, without promises about aging, lifespan or disease.
How to design a longevity telehealth business program
Most longevity programs are built in layers. Each layer should be something a provider can use, and each should be described accurately to patients.
| Program layer | What it includes | Key founder decision |
|---|---|---|
| Labs | Baseline panels, such as metabolic, lipid, thyroid and hormone markers, as the provider decides | Which panels, which collection methods, how results are reviewed |
| Provider evaluation | Review of intake, history, medications and labs by a licensed provider | Async or live visit, based on state rules and treatment |
| Hormone therapy | Testosterone, estrogen and progesterone therapies where appropriate | Controlled substance rules, lab monitoring, contraindication screening |
| NAD+ and peptides | Only through licensed pharmacies with a valid prescription | Current regulatory status of every substance |
| Wearables and monitoring | Smart rings, smartwatches, CGMs, blood pressure cuffs, smart scales | What data providers will review and how often |
| Ongoing care | Follow-up labs, messaging, refills, check-ins | Membership or program structure and renewal timing |
Labs first
Labs give the provider a starting point and give the patient a clear record of their own markers. Build baseline panels with your clinical team, offer convenient collection (at-home phlebotomy, service center draws or at-home kits) and set a results review protocol before launch. Our guide on how to add lab testing to telehealth covers CLIA, state rules on direct access testing and the results workflow.
Provider evaluation
Every patient should be evaluated by a provider licensed in the patient’s state. The provider reviews intake, medications, history and labs, and decides what, if anything, is appropriate. Some states require a live audio or video visit to establish care, and controlled substances have their own federal rules. Your platform should route each patient to async review or a live visit based on state and treatment.
Hormone therapy
Hormone therapy is common in longevity programs, and it needs the most care. Testosterone is a Schedule III controlled substance, so federal DEA telemedicine rules and state law both apply. At the time of writing, the DEA telemedicine flexibilities run through December 31, 2026, and a permanent framework was still pending, so verify current rules before you build. Screening, lab monitoring and clear consent are essential. Our guides on how to start a TRT digital clinic and how to start a perimenopause and menopause telehealth clinic go deeper.
NAD+ telehealth programs
NAD+ is one of the most requested longevity treatments. On FDA’s list of bulk drug substances nominated for 503A compounding, updated May 14, 2026, nicotinamide adenine dinucleotide (NAD) appeared in category 1, substances under evaluation. Category 1 means FDA has said it does not intend to take action against compounders who meet its interim policy conditions while it evaluates the substance. It is interim policy, not approval, and it can change. Compounded NAD+ is not FDA-approved, and your marketing must describe it accurately without health claims.
Peptides, only through legitimate pathways
Peptides are popular in longevity marketing and highly scrutinized by FDA. Offer only FDA-approved products or compounded preparations from licensed pharmacies that meet federal bulk substance rules, prescribed by a licensed provider for an individual patient. Never sell, recommend or link to research-use-only products. Peptide status is changing quickly, so read how to start a peptide telehealth business and have counsel confirm each product.
Wearables
Wearables add data between lab draws. Patients can connect smart rings, smartwatches, CGMs, blood pressure cuffs and smart scales, often through phone health hubs such as Apple Health and Google Health Connect. Decide what providers will actually review, tell patients how the data is used and never present consumer devices as diagnostic. See telehealth lab testing and wearables.
Compliance: what you must get right to start a longevity clinic
Compounded medications are not FDA-approved
FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. In its guidance to telehealth companies, FDA warns against saying a compounded drug is FDA-approved, is a generic version of an approved drug, is clinically proven to produce the same result as an approved drug, or comes from an “FDA-approved” pharmacy. FDA does not approve pharmacies. Our guide What Is a 503A Pharmacy? explains how compounding works.
Understand the 503A bulk substance categories
Under section 503A of the Federal Food, Drug, and Cosmetic Act, a pharmacy compounding from a bulk substance generally must use one that has a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA’s 503A bulks list. While FDA evaluates nominated substances, it sorts them into interim categories:
- Category 1: substances under evaluation, where FDA has said it does not intend to act against compounders meeting certain conditions
- Category 2: substances FDA has identified as raising significant safety risks
- Category 3: substances nominated without adequate support
These categories are interim and change. Ask your pharmacy partners for the legal basis for every product, and have a healthcare attorney confirm your formulary on a regular schedule.
Avoid disease and anti-aging claims
Longevity marketing drifts into claims easily. Words like “reverse aging,” “add years to your life,” “lower your biological age,” “prevent disease” or “cellular repair” are objective health claims. Under the FTC’s Health Products Compliance Guidance, issued in December 2022, health claims need competent and reliable scientific evidence, and the FTC says randomized, controlled human clinical trials are generally the type of substantiation experts would require for health benefit claims. For prescription and compounded drugs, FDA rules on drug claims apply as well.
Safer framing describes what the program includes, not what it will do:
- Describe the process: labs, provider review, individualized plans, ongoing check-ins
- Say that treatment is prescribed only if a licensed provider decides it is appropriate
- Include clear disclosures that compounded medications are not FDA-approved
- Skip before and after claims, lifespan claims and testimonials that imply typical results
Advertising, payments and privacy
Major ad platforms require certification such as LegitScript for prescription drug advertising. See how to get LegitScript certification for telehealth. Payment processors review longevity and compounding categories closely, and every vendor that handles protected health information should sign a business associate agreement. Our telehealth compliance checklist pulls these items together.
Designing the patient experience for an online longevity clinic
Longevity patients tend to be engaged, curious and data-minded. The experience should feel organized, clear and personal.
- Clear onboarding. Explain what happens first, second and third, including labs, provider review and timelines.
- Easy lab collection. Offer more than one collection method so patients can choose.
- Readable results. Results appear in the patient’s branded app with plain-language context and a way to ask questions.
- A real provider relationship. Secure messaging, follow-up visits when needed and clear escalation to urgent care for any emergency symptoms.
- Transparent billing. Clear membership or program terms, refill timing and cancellation policies.
- Ongoing rhythm. Follow-up labs and check-ins at the intervals the provider sets.
How to start a longevity clinic online: step by step
- Define your patient and scope. Decide who you serve and which program layers you will offer at launch.
- Get legal guidance. Work with a healthcare attorney on entity structure, corporate practice of medicine rules and your formulary. If you are not a clinician, ask about the MSO and PC model.
- Build your formulary from pathways. FDA-approved products and compounded preparations counsel has confirmed, from licensed pharmacies.
- Secure licensed providers. Confirm state coverage and that providers are comfortable with each program layer.
- Set up labs and wearables. Choose panels, collection methods and a results review protocol.
- Write an intake with real screening. History, medications, contraindications, pregnancy status and goals.
- Start merchant processing and LegitScript early. Longevity and compounding categories often draw extra review.
- Review every claim. Site, ads, emails, social and affiliate content, against FTC and FDA standards.
- Test the full journey. Run test orders from intake through labs, review, prescription and delivery.
- Launch and recheck. Schedule regular reviews of product status and marketing.
Common mistakes longevity founders make
- Leading with products instead of evaluation. A menu of treatments without labs and provider review is not a clinic.
- Calling compounded products FDA-approved. They are not.
- Selling research-use-only peptides. Never, in any form.
- Making anti-aging promises. Lifespan and disease claims need substantiation you likely do not have.
- Forgetting controlled substance rules. Testosterone programs need a plan for DEA and state requirements.
- Collecting data no one reviews. Wearables and labs only help if the workflow uses them.
How WellieMD helps
WellieMD is a white-label telehealth platform built to run a longevity program under your brand. It includes branded intake, a licensed provider network, licensed 503A pharmacy routing, payments and subscriptions, refills, and labs and wearables in one chart, with 15,000+ lab tests across 20+ lab partners including Quest and Labcorp, at-home phlebotomy, service center draws and at-home kits. It is HIPAA-ready with a business associate agreement. WellieMD works only with prescription pathways through licensed pharmacies, and all clinical decisions stay with licensed providers. If you are mapping out a longevity brand, book a demo and we will build it with you.
Frequently asked questions
Do I need to be a doctor to start a longevity clinic?
No. Many founders are operators or marketers who work with licensed providers for all evaluation and prescribing. How ownership is structured depends on your state, including corporate practice of medicine rules. A healthcare attorney can tell you what applies.
Is NAD+ FDA-approved?
Compounded NAD+ is not FDA-approved. On FDA’s 503A list updated May 14, 2026, NAD was in category 1, substances under evaluation, which is interim policy and not approval. Describe NAD+ accurately and avoid health claims.
Can I offer peptides in a longevity telehealth business?
Only through legitimate prescription pathways: FDA-approved products or compounded preparations from licensed pharmacies that meet federal bulk substance rules, prescribed by a licensed provider. Research-use-only products are never for patients. Peptide status changes often, so confirm each product with counsel.
Can I market a longevity clinic as anti-aging?
Be very careful. Claims like reversing aging, adding years or preventing disease are health claims that the FTC expects to be backed by competent and reliable scientific evidence. Describe your program, labs and provider process instead of promising outcomes.
Do longevity programs require labs?
Most credible programs start with labs, because they give the licensed provider objective information for evaluation. The provider decides which tests are appropriate and whether follow-up testing is needed. State rules on direct access testing vary, so confirm each state.
This guide is general information, not legal or medical advice. Prescription products require evaluation by a licensed provider. Compounded medications are not FDA-approved.
Sources
- U.S. Food and Drug Administration: Bulk drug substances used in compounding under section 503A of the FD&C Act
- U.S. Food and Drug Administration: Bulk drug substances nominated for use in compounding under section 503A, categories 1, 2 and 3 (updated May 14, 2026)
- U.S. Food and Drug Administration: FDA to telehealth companies, what to know when promoting compounded drugs
- Federal Trade Commission: Health Products Compliance Guidance
- Federal Register: Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications